Login

CEO Jessica Skon Highlights BTS Group's Record Quarter in Discussion with Equity Analyst Rikard Engberg | Jessica Skon - CEO of BTS group 00:10:00

Share On Facebook Share On Twitter

Jessica Skon is the President & CEO, BTS Group

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Darrell S. Pardi, M.D. Gastroenterologist, Mayo Clinic / Diagnosing and treating digestive tract and liver disorders
00:10:00
"An Interview with Meb Faber, Chief Investment Officer of Cambria Investment Management"
00:10:00
Old Peak Finance: The Smartest Way for Retirees to Give with Qualified Charitable Distributions (QCDs)
00:10:00
Mastering Market Movements: A Day in the Life of a Long/Short Equity Analyst | Sarah Johnson - Equity Analyst, Point72
00:10:00
John Zhao on Bridging Tech Innovation Across Borders | John Zhao, Managing Director , Hillhouse Capital Group.
00:10:00
First check fund backing dropouts renegade students and deep tech scientists before anyone else|Danielle Strachman, General Partner,1517 Fund
00:10:00
Understanding the Four Pillars of Capital: Insights from Caspar Helmore | Caspar Helmore, Partner - Client Management
00:10:00
Exploring Lithium Potential in Argentina: Portofino Resources CEO David Tafel Discusses Strategic Focus
00:10:00
Global Nickel Market: Challenges and Opportunities
00:10:00
Larry Fink on Cryptocurrencies and Cybersecurity Concerns | Larry Fink , CEO, BlackRock Inc.
00:10:00
Insights from BKW's CEO on his first 100 days, including surprises, priorities, and ambitious goals for the future |Robert Itschner, CEO, BKW AG.
00:10:00
Sirius Minerals CEO Chris Fraser expresses satisfaction with the $1.2 billion financing plan for the Polyhalite mine in North Yorkshire, highlighting the milestone achievement and emphasis on minimizing dilution while unlocking project value.|Mr. Christop

© 2017 - Neuhu+